You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 86 No. 2, August 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTES, NEW INSTRUMENTS AND TECHNIQUES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Topical Oxytetracycline-Polymyxin—Further Observations

Use of Powder Without Allergic Eczematous Reactions

SHERWOOD W. BAREFOOT, M.D.

Arch Dermatol. 1962;86(2):236.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In 1959, I reported on the use of oxytetracycline hydrochloride (Terramycin)-polymyxin B sulfate powder* in 5,691 patients without significant allergic reactions.1 Since that report, I have had the opportunity to use this preparation on more than 5,500 additional patients with dermatological problems similar to those in the previous report.

Summary

Together with 5,691 cases in a previous report, the present series of 5,500 cases brings to over 11,000 the total number of patients treated by me with a powder containing 3.31% oxytetracycline hydrochloride and 0.144% polymyxin B sulfate in U.S.P. lactose. In not a single case has there been observed a definite instance of eczematous dermatitis from the topical use of oxytetracycline hydrochloride or of polymyxin B sulfate.

Conclusion

With the powder preparation studied, allergic eczematous dermatitis from the topical use of oxytetracycline hydrochloride or polymyxin B sulfate would seem to be virtually nonexistent.

Sherwood W. Barefoot, M.D., 1030 . . . [Full Text PDF of this Article]


Author Affiliations

GREENSBORO, N.C.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.